{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:07:37Z","timestamp":1778998057884,"version":"3.51.4"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.imlet.2025.107031","type":"journal-article","created":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T13:38:59Z","timestamp":1746970739000},"page":"107031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Low IL-35 expression in CSF is associated with Neuro-Behcet Disease: Comparative analysis between parenchymal and Non-parenchymal NBD"],"prefix":"10.1016","volume":"275","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9149-6934","authenticated-orcid":false,"given":"Kamel","family":"Hamzaoui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fay\u00e7alHaj","family":"Sassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariem","family":"Salhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6061-6649","authenticated-orcid":false,"given":"Agn\u00e8s","family":"Hamzaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2025.107031_bib0001","article-title":"Chemokines and chemokine receptors in Beh\u00e7et's disease","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2025.107031_bib0002","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.clineuro.2009.02.001","article-title":"CSF levels of cytokines in neuro-Beh\u00e7et's disease","volume":"111","author":"Borhani Haghighi","year":"2009","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.imlet.2025.107031_bib0003","first-page":"170","article-title":"The cerebrospinal fluid presentations of neuro-bechet disease, a way to know \u200ethe etiopathogenesis and improve armamentarium\u200e","volume":"18","author":"Banerjee","year":"2021","journal-title":"Iran. J. Immunol."},{"key":"10.1016\/j.imlet.2025.107031_bib0004","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/B978-0-7020-4088-7.00110-3","article-title":"Neuro-beh\u00e7et syndrome","volume":"121","author":"Saip","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.imlet.2025.107031_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117436","article-title":"An uncommon disease included commonly in the differential diagnosis of neurological diseases: neuro-Beh\u00e7et\u2019s syndrome","volume":"426","author":"Uygunoglu","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.imlet.2025.107031_bib0006","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3174\/ajnr.A2477","article-title":"Evaluation of parenchymal neuro-beh\u00e7et disease by using susceptibility-weighted imaging","volume":"32","author":"Ceyhan","year":"2011","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.imlet.2025.107031_bib0007","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3174\/ajnr.A2477","article-title":"Evaluation of parenchymal neuro-beh\u00e7et disease by using susceptibility-weighted imaging","volume":"32","author":"Albayram","year":"2011","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.imlet.2025.107031_bib0008","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jneuroim.2011.01.012","article-title":"RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Beh\u00e7et's disease","volume":"222","author":"Hamzaoui","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imlet.2025.107031_bib0009","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/rheumatology\/keab253","article-title":"Regulatory T cell\/Th17 balance in the pathogenesis of paediatric Beh\u00e7et disease","volume":"61","author":"Filleron","year":"2021","journal-title":"Rheumatology. (Oxford)"},{"key":"10.1016\/j.imlet.2025.107031_bib0010","article-title":"Genetic analysis of innate immunity in Behcet's disease identifies an association with IL-37 and IL-18RAP","volume":"24","author":"Tan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imlet.2025.107031_bib0011","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.amjms.2022.04.013","article-title":"Interleukin 37; a possible marker of arterial stiffness in Beh\u00e7et's disease","volume":"364","author":"Hussein","year":"2022","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.imlet.2025.107031_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2024.106840","article-title":"IL-38 in Beh\u00e7et's disease: gene expression in bronchoalveolar lavage from patients having pulmonary involvement","volume":"266","author":"Hamzaoui","year":"2024","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imlet.2025.107031_bib0013","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.autrev.2018.01.017","article-title":"Emerging role of IL-35 in inflammatory autoimmune diseases","volume":"17","author":"Su","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"12","key":"10.1016\/j.imlet.2025.107031_bib0014","article-title":"A chaperone-like role for EBI3 in collaboration with Calnexin under inflammatory conditions","volume":"17","author":"Watanabe","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2025.107031_bib0015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/jir.2021.0147","article-title":"Interleukin-35: structure, function and its impact on immune-related diseases","volume":"41","author":"Ye","year":"2021","journal-title":"J. Interferon. Cytokine Res."},{"issue":"1","key":"10.1016\/j.imlet.2025.107031_bib0016","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028563","article-title":"Inflammasome-dependent cytokines at the crossroads of health and autoinflammatory disease","volume":"11","author":"Van Gorp","year":"2019","journal-title":"Cold. Spring. Harb. Perspect. Biol."},{"issue":"3","key":"10.1016\/j.imlet.2025.107031_bib0017","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028506","article-title":"Interleukin (IL)-33 and the IL-1 Family of cytokines-regulators of inflammation and tissue homeostasis","volume":"11","author":"Vasanthakumar","year":"2019","journal-title":"Cold. Spring. Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.imlet.2025.107031_bib0018","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00296-019-04389-3","article-title":"IL-1\u03b2 blockade in periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome: case-based review","volume":"41","author":"Soylu","year":"2021","journal-title":"Rheumatol. Int."},{"issue":"1","key":"10.1016\/j.imlet.2025.107031_bib0019","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5152\/eurjrheum.2020.20126","article-title":"Efficacy of anti-interleukin-1 treatment in colchicine-resistant arthritis in patients with familial Mediterranean fever","volume":"8","author":"Kehribar","year":"2021","journal-title":"Eur. J. Rheumatol."},{"issue":"7","key":"10.1016\/j.imlet.2025.107031_bib0020","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.7150\/thno.90608","article-title":"Adaptive plasticity of natural interleukin-35-induced regulatory T cells (Tr35) that are required for T-cell immune regulation","volume":"14","author":"Wei","year":"2024","journal-title":"Theranostics."},{"key":"10.1016\/j.imlet.2025.107031_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111567","article-title":"IL-35 ameliorates lipopolysaccharide-induced endothelial dysfunction by inhibiting endothelial-to-mesenchymal transition","volume":"129","author":"Feng","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.imlet.2025.107031_bib0022","doi-asserted-by":"crossref","first-page":"758","DOI":"10.4067\/S0034-98872010000600015","article-title":"Interleukin (IL)-35 is raising our expectations","volume":"138","author":"Ning-Wei","year":"2010","journal-title":"Rev. Med. Chil."},{"key":"10.1016\/j.imlet.2025.107031_bib0023","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1007\/s00415-013-7209-3","article-title":"Diagnosis and management of Neuro-Beh\u00e7et\u2019s disease: international consensus recommendations","volume":"261","author":"Kalra","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.imlet.2025.107031_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101906","article-title":"Neuro-Behcet's disease: an update on diagnosis, differential diagnoses, and treatment","volume":"39","author":"Borhani-Haghighi","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.imlet.2025.107031_bib0025","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.imlet.2025.107031_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577820","article-title":"Elevated levels of IL-32 in cerebrospinal fluid of neuro-behcet disease: correlation with NLRP3 inflammasome","volume":"365","author":"Hamzaoui","year":"2022","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.imlet.2025.107031_bib0027","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.imbio.2015.09.009","article-title":"Anti-inflammatory activity of IL-37 in asthmatic children: correlation with inflammatory cytokines TNF-\u03b1, IL-\u03b2, IL-6 and IL-17A","volume":"221","author":"Charrad","year":"2016","journal-title":"Immunobiology"},{"key":"10.1016\/j.imlet.2025.107031_bib0028","doi-asserted-by":"crossref","first-page":"588","DOI":"10.20344\/amp.19734","article-title":"Diagn\u00f3stico e Tratamento do Neuro-Beh\u00e7et: uma Actualiza\u00e7\u00e3o Cl\u00ednica [Diagnosis and Treatment of Neuro-Beh\u00e7et: a Clinical Update]","volume":"36","author":"ilva","year":"2023","journal-title":"Acta Med. Port."},{"key":"10.1016\/j.imlet.2025.107031_bib0029","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s004150170242","article-title":"Beh\u00e7et's disease: diagnostic and prognostic aspects of neurological involvement","volume":"248","author":"Siva","year":"2001","journal-title":"J. Neurol."},{"key":"10.1016\/j.imlet.2025.107031_bib0030","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/ni.2227","article-title":"The composition and signaling of the IL-35 receptor are unconventional","volume":"13","author":"Collison","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2025.107031_bib0031","first-page":"223","article-title":"Interleukin-35 inhibits angiogenesis through STAT1 signalling in rheumatoid synoviocytes","volume":"36","author":"Wu","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.imlet.2025.107031_bib0032","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/imm.13044","article-title":"Interleukin-35 in immune-related diseases: protection or destruction","volume":"157","author":"Zhang","year":"2019","journal-title":"Immunology"},{"key":"10.1016\/j.imlet.2025.107031_bib0033","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.coi.2009.09.011","article-title":"Regulatory T cells and inhibitory cytokines in autoimmunity","volume":"21","author":"Bettini","year":"2009","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2025.107031_bib0034","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/1756-185X.13962","article-title":"Interleukin-35 regulates the balance of Th17 and treg responses during the pathogenesis of connective tissue diseases","volume":"24","author":"Wang","year":"2021","journal-title":"Int. J. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.imlet.2025.107031_bib0035","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jaci.2011.07.008","article-title":"Regulation of TH17 and regulatory T cells in patients with Beh\u00e7et disease","volume":"128","author":"Direskeneli","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2025.107031_bib0036","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/BOR.0b013e3282f154d1","article-title":"Beh\u00e7et's disease","volume":"20","author":"Krause","year":"2008","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.imlet.2025.107031_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1387975","article-title":"Regulation of treg cells by cytokine signaling and co-stimulatory molecules","volume":"15","author":"Zong","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2025.107031_bib0038","doi-asserted-by":"crossref","first-page":"uxae123","DOI":"10.1093\/cei\/uxae123","article-title":"Neuro-Beh\u00e7et's disease: an update of clinical diagnosis, biomarkers, and immunopathogenesis","volume":"219","author":"Zhan","year":"2025","journal-title":"Clin. Exp. Immunol."},{"issue":"12","key":"10.1016\/j.imlet.2025.107031_bib0039","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1523\/JNEUROSCI.1815-18.2019","article-title":"Regulatory T cells and their derived cytokine, interleukin-35, reduce pain in experimental autoimmune encephalomyelitis","volume":"39","author":"Duffy","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.imlet.2025.107031_bib0040","doi-asserted-by":"crossref","first-page":"7960","DOI":"10.3390\/ijms24097960","article-title":"Autoimmune Neuroinflammatory diseases: role of interleukins","volume":"24","author":"AW Farooq","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imlet.2025.107031_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2014.05.009","article-title":"IL1-\u03b2 expression in multiple sclerosis","volume":"343","author":"Maghzi","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.imlet.2025.107031_bib0042","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-510X(00)00397-X","article-title":"Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Beh\u00e7et's disease","volume":"179","author":"Niino","year":"2000","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.imlet.2025.107031_bib0043","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.21873\/invivo.11629","article-title":"Enhanced NLRP3 and DEFA1B expression during the active stage of Parenchymal Neuro-Beh\u00e7et's disease","volume":"33","author":"Ugurel","year":"2019","journal-title":"In Vivo (Brooklyn)"},{"issue":"1","key":"10.1016\/j.imlet.2025.107031_bib0044","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/BOR.0000000000000962","article-title":"Vasculitis and the NLRP3 inflammasome","volume":"36","author":"Hamzaoui","year":"2024","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.imlet.2025.107031_bib0045","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1084\/jem.179.6.1895","article-title":"The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor","volume":"179","author":"Calandra","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2025.107031_bib0046","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.bbi.2013.12.011","article-title":"Up-regulation of interleukin-23 induces persistent allodynia via CX3CL1 and interleukin-18 signaling in the rat spinal cord after tetanic sciatic stimulation","volume":"37","author":"Bian","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.imlet.2025.107031_bib0047","doi-asserted-by":"crossref","first-page":"12775","DOI":"10.1523\/JNEUROSCI.3512-08.2008","article-title":"Interleukin-18- mediated microglia\/astrocyte interaction in the spinal cord enhances neuropathic pain processing after nerve injury","volume":"28","author":"Miyoshi","year":"2008","journal-title":"J. Neurosci."},{"issue":"10431","key":"10.1016\/j.imlet.2025.107031_bib0048","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(23)02629-6","article-title":"Beh\u00e7et's syndrome","volume":"403","author":"Emmi","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.imlet.2025.107031_bib0049","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/cmi.2014.31","article-title":"Increased interleukin 33 in patients with neuro-Behcet's disease: correlation with MCP-1 and IP-10 chemokines","volume":"11","author":"Hamzaoui","year":"2014","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.imlet.2025.107031_bib0050","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5001\/omj.2016.08","article-title":"Increased concentrations of interleukin-33 in the serum and cerebrospinal fluid of patients with multiple sclerosis","volume":"31","author":"Jafarzadeh","year":"2016","journal-title":"Oman. Med. J."},{"key":"10.1016\/j.imlet.2025.107031_bib0051","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1742-2094-11-94","article-title":"Evaluating the levels of interleukin-1 family cytokines in sporadic amyotrophic lateral sclerosis","volume":"11","author":"Italiani","year":"2014","journal-title":"J. Neuroinflammat."},{"key":"10.1016\/j.imlet.2025.107031_bib0052","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mehy.2015.11.022","article-title":"In-situ expression of Interleukin-18 and associated mediators in the human brain of sALS patients: hypothesis for a role for immune-inflammatory mechanisms","volume":"86","author":"Kadhim","year":"2016","journal-title":"Med. Hypotheses."},{"key":"10.1016\/j.imlet.2025.107031_bib0053","article-title":"Beh\u00e7et's syndrome in a Chinese pedigree of NLRP3-associated autoinflammatory disease: a coexistence or novel presentation?","volume":"24","author":"Liu","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.imlet.2025.107031_bib0054","first-page":"155","article-title":"Clinicopathologic studies on neuro-Beh\u00e7et\u2019s disease","volume":"39","author":"Totsuka","year":"1985","journal-title":"Folia Psychiatr. Neurol. Jpn."},{"key":"10.1016\/j.imlet.2025.107031_bib0055","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.neuron.2015.01.013","article-title":"The glia-derived alarmin IL-33 orchestrates the immune response and promotes recovery following CNS injury","volume":"85","author":"Gadani","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.imlet.2025.107031_bib0056","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.brainres.2011.02.045","article-title":"Production and functions of IL-33 in the central nervous system","volume":"1385","author":"Yasuoka","year":"2011","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.imlet.2025.107031_bib0057","first-page":"1249","article-title":"Decreased serum levels of interleukin-35 among multiple sclerosis patients may be related to disease progression","volume":"32","author":"Badihian","year":"2018","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.imlet.2025.107031_bib0058","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/5584_2020_488","article-title":"Interleukin-36: structure, signaling and function","volume":"21","author":"Zhou","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.imlet.2025.107031_bib0059","doi-asserted-by":"crossref","DOI":"10.1136\/ard-2023-225158","article-title":"Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis","author":"Gr\u00f6nberg","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.imlet.2025.107031_bib0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.imbio.2019.02.008","article-title":"Interleukin-36 alpha levels are elevated in the serum and cerebrospinal fluid of patients with neuromyelitis optica spectrum disorder and correlate with disease activity","volume":"224","author":"Song","year":"2019","journal-title":"Immunobiology"},{"key":"10.1016\/j.imlet.2025.107031_bib0061","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/BOR.0000000000000361","article-title":"The novel interleukin-1 cytokine family members in inflammatory diseases","volume":"29","author":"Hahn","year":"2017","journal-title":"Curr. Opin. Rheumatol."},{"issue":"1","key":"10.1016\/j.imlet.2025.107031_bib0062","doi-asserted-by":"crossref","first-page":"uxae123","DOI":"10.1093\/cei\/uxae123","article-title":"Neuro-Beh\u00e7et's disease: an update of clinical diagnosis, biomarkers, and immunopathogenesis","volume":"219","author":"Zhan","year":"2025","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2025.107031_bib0063","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1321228","article-title":"Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity","volume":"14","author":"Santosh Nirmala","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2025.107031_bib0064","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.3892\/etm.2016.3649","article-title":"IL-35 improves Treg-mediated immune suppression in atherosclerotic mice","volume":"12","author":"Tao","year":"2016","journal-title":"Exp. Ther. Med."},{"issue":"12","key":"10.1016\/j.imlet.2025.107031_bib0065","article-title":"Interleukin-35 mitigates the function of murine transplanted islet cells via regulation of Treg\/Th17 ratio","volume":"12","author":"Zongzi","year":"2017","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.imlet.2025.107031_bib0066","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5114\/ceji.2023.125043","article-title":"Interleukin 35: protective role and mechanism in type 1 diabetes","volume":"48","author":"Zhang","year":"2023","journal-title":"Cent. Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2025.107031_bib0067","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/gt.2011.32","article-title":"Use of cytokine immunotherapy to block CNS demyelination induced by a recombinant HSV-1 expressing IL-2","volume":"18","author":"Zandian","year":"2011","journal-title":"Gene Ther."},{"issue":"10","key":"10.1016\/j.imlet.2025.107031_bib0068","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.3390\/ijms22105329","article-title":"Epigenetic DNA methylation of EBI3 modulates Human interleukin-35 formation via NFkB signaling: a promising therapeutic option in ulcerative colitis","volume":"22","author":"Wetzel","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imlet.2025.107031_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156501","article-title":"A glance on the role of IL-35 in systemic lupus erythematosus (SLE)","volume":"176","author":"Bahadorian","year":"2024","journal-title":"Cytokine"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247825000641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247825000641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:05:11Z","timestamp":1762250711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247825000641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":69,"alternative-id":["S0165247825000641"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107031","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low IL-35 expression in CSF is associated with Neuro-Behcet Disease: Comparative analysis between parenchymal and Non-parenchymal NBD","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2025.107031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Federation of Immunological Societies. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107031"}}